BCL2 and melanoma: Thus suggesting that Bcl-xl and Bcl-2 are not functionally interchangeable in vivo, and that Bcl-2 alone (despite down regulation of bax and up-regulation of bcl-xl) could be a relevant target in melanoma therapy.